Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US
Objective: Pyrethroids-containing products are widely used as commercial and household insecticides. While animal studies and clinical case reports have shown acute cardiovascular outcomes of pyrethroids exposure, little has been known on the effect of chronic pyrethroid exposure on cardiovascular d...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Environment International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0160412021001707 |
id |
doaj-3b94a09007274207a6c00bb3f383d2bb |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qingping Xue An Pan Ying Wen Yichao Huang Da Chen Chun-Xia Yang Jason HY Wu Jie Yang Jay Pan Xiong-Fei Pan |
spellingShingle |
Qingping Xue An Pan Ying Wen Yichao Huang Da Chen Chun-Xia Yang Jason HY Wu Jie Yang Jay Pan Xiong-Fei Pan Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US Environment International Pyrethroids 3-phenoxybenzoic acid Cardiovascular disease Coronary heart disease Stroke |
author_facet |
Qingping Xue An Pan Ying Wen Yichao Huang Da Chen Chun-Xia Yang Jason HY Wu Jie Yang Jay Pan Xiong-Fei Pan |
author_sort |
Qingping Xue |
title |
Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US |
title_short |
Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US |
title_full |
Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US |
title_fullStr |
Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US |
title_full_unstemmed |
Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US |
title_sort |
association between pyrethroid exposure and cardiovascular disease: a national population-based cross-sectional study in the us |
publisher |
Elsevier |
series |
Environment International |
issn |
0160-4120 |
publishDate |
2021-08-01 |
description |
Objective: Pyrethroids-containing products are widely used as commercial and household insecticides. While animal studies and clinical case reports have shown acute cardiovascular outcomes of pyrethroids exposure, little has been known on the effect of chronic pyrethroid exposure on cardiovascular disease (CVD). We aimed to examine the associations between chronic pyrethroid exposure and CVD in the US adults. Methods: Cross-sectional data from the National Health and Nutrition Examination Survey 1999–2002 and 2007–2012 were analyzed. The exposure to pyrethroids was determined as the urinary level of 3-phenoxybenzoic acid (3-PBA), and CVD was ascertained based on self-reported physician diagnoses. Multivariable logistic regression models were fitted to evaluate associations of pyrethroid exposure with CVD, coronary heart disease (CHD), and stroke. Results: Included were 6,471 participants with a mean age of 44.77 years (standard error, 0.39) for final analyses. The weighted prevalence of CVD, CHD, and stroke was 6.85%, 4.57% and 2.27%, respectively. With adjustments for major confounders, participants in the highest tertile of urinary 3-PBA had higher odds of CVD (odds ratio, 1.58; 95% confidence interval: 1.12, 2.23) and CHD (OR, 1.75; 95% CI: 1.17, 2.61) compared to those in the lowest tertile. There were linear associations for CVD (P for trend = 0.04) and CHD (P for trend = 0.02). However, no significant association was noted for stroke (1.29; 0.78, 2.16) in the main analyses. Conclusions: 3-PBA was adversely associated with CVD and CHD in the US adults. Our findings highlight potential cardiovascular risk of chronic exposure to pyrethroids, and should be validated in large prospective studies in different populations in future. |
topic |
Pyrethroids 3-phenoxybenzoic acid Cardiovascular disease Coronary heart disease Stroke |
url |
http://www.sciencedirect.com/science/article/pii/S0160412021001707 |
work_keys_str_mv |
AT qingpingxue associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT anpan associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT yingwen associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT yichaohuang associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT dachen associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT chunxiayang associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT jasonhywu associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT jieyang associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT jaypan associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus AT xiongfeipan associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus |
_version_ |
1721430856401158144 |
spelling |
doaj-3b94a09007274207a6c00bb3f383d2bb2021-05-22T04:35:22ZengElsevierEnvironment International0160-41202021-08-01153106545Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the USQingping Xue0An Pan1Ying Wen2Yichao Huang3Da Chen4Chun-Xia Yang5Jason HY Wu6Jie Yang7Jay Pan8Xiong-Fei Pan9Department of Epidemiology and Biostatistics, School of Public Health, Chengdu Medical College, Chengdu, Sichuan, China; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, ChinaDepartment of Epidemiology and Biostatistics, Ministry of Education & Ministry of Environmental Protection Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaShenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, ChinaSchool of Environment and Guangdong Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, Guangdong, ChinaSchool of Environment and Guangdong Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, Guangdong, ChinaDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, ChinaThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, AustraliaInternational Clinical Research Center & Department of Neurology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, ChinaHEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China; Institue for Healthy Cities, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China; Corresponding authors at: Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 3-17 Renmin Nanlu, Chengdu, Sichuan Province 610041, China (J. Pan). Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Rd, Wuhan 430030, China (X.-F. Pan).Department of Epidemiology and Biostatistics, Ministry of Education & Ministry of Environmental Protection Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Corresponding authors at: Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 3-17 Renmin Nanlu, Chengdu, Sichuan Province 610041, China (J. Pan). Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Rd, Wuhan 430030, China (X.-F. Pan).Objective: Pyrethroids-containing products are widely used as commercial and household insecticides. While animal studies and clinical case reports have shown acute cardiovascular outcomes of pyrethroids exposure, little has been known on the effect of chronic pyrethroid exposure on cardiovascular disease (CVD). We aimed to examine the associations between chronic pyrethroid exposure and CVD in the US adults. Methods: Cross-sectional data from the National Health and Nutrition Examination Survey 1999–2002 and 2007–2012 were analyzed. The exposure to pyrethroids was determined as the urinary level of 3-phenoxybenzoic acid (3-PBA), and CVD was ascertained based on self-reported physician diagnoses. Multivariable logistic regression models were fitted to evaluate associations of pyrethroid exposure with CVD, coronary heart disease (CHD), and stroke. Results: Included were 6,471 participants with a mean age of 44.77 years (standard error, 0.39) for final analyses. The weighted prevalence of CVD, CHD, and stroke was 6.85%, 4.57% and 2.27%, respectively. With adjustments for major confounders, participants in the highest tertile of urinary 3-PBA had higher odds of CVD (odds ratio, 1.58; 95% confidence interval: 1.12, 2.23) and CHD (OR, 1.75; 95% CI: 1.17, 2.61) compared to those in the lowest tertile. There were linear associations for CVD (P for trend = 0.04) and CHD (P for trend = 0.02). However, no significant association was noted for stroke (1.29; 0.78, 2.16) in the main analyses. Conclusions: 3-PBA was adversely associated with CVD and CHD in the US adults. Our findings highlight potential cardiovascular risk of chronic exposure to pyrethroids, and should be validated in large prospective studies in different populations in future.http://www.sciencedirect.com/science/article/pii/S0160412021001707Pyrethroids3-phenoxybenzoic acidCardiovascular diseaseCoronary heart diseaseStroke |